Reduced exercise capacity in genetic haemochromatosis
Einar Skulstad Davidsen1, Knut Liseth, Per Omvik
1Department of Heart Disease, Haukeland University Hospital, University of Bergen, Norway. einar.davidsen@helse-bergen.no
Summary
Patients with genetic haemochromatosis experience reduced exercise capacity, even with phlebotomy treatment. This study found lower peak oxygen uptake in patients, independent of other factors.
Area of Science:
- Cardiology
- Exercise Physiology
- Genetics
Background:
- Genetic haemochromatosis often presents with fatigue and reduced physical capacity.
- Exercise capacity in treated haemochromatosis patients has not been extensively studied.
Purpose of the Study:
- To evaluate exercise capacity in a large cohort of treated genetic haemochromatosis patients.
- To compare exercise capacity between haemochromatosis patients and healthy controls.
Main Methods:
- Exercise echocardiography and ventilatory gas exchange measurements were performed on 152 treated haemochromatosis patients and 50 healthy controls.
- Measurements included transmitral flow, isovolumic relaxation time, and peak oxygen uptake during incremental exercise.
- Data were analyzed using multiple regression to identify independent predictors of exercise capacity.
Main Results:
- Haemochromatosis patients exhibited significantly lower peak oxygen uptake compared to controls (28.1 vs. 34.4 ml/kg per min).
- Genetic haemochromatosis independently predicted lower peak oxygen uptake, irrespective of sex, age, height, blood pressure, or relaxation time.
- Obesity, lower fitness levels, smoking, and cardiovascular history were more prevalent in patients but did not fully explain the reduced exercise capacity.
Conclusions:
- Treated genetic haemochromatosis is associated with diminished exercise capacity.
- This reduced capacity persists independently of common factors influencing physical performance.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:20Exercise and Cardiovascular Response
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:24Factors Affecting Erythropoiesis
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...